Hormone replacement therapy, used by women to alleviate the symptoms of menopause, should be used only if absolutely necessary.

That’s the message of two new reports that add to evidence of HRT’s cancer risks. Investigators at the M.D. Anderson Cancer Center say that a continued decline in national breast cancer diagnoses dovetails with a decline in HRT use.

The connection was established in 2002, when a study of Prempro, the most popular menopause drug, was halted it appeared to increase risks of both heart disease and breast cancer. Prempro sales plummeted, followed quickly by a drop in breast cancer.

The other report, produced by the UK’s Million Woman Study, suggests that HRT-caused ovarian cancers killed 1,000 British women between 1991 and 2005.

When used, say doctors, HRT drugs should be taken “at the smallest possible dose for the shortest possible time.”



We're here to help!

We live by our creed of “helping those who need it most” and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked * may be required for submission.


The extra mile

I can't thank Beasley Allen enough for their excellent and hard work. At every point, they went the extra mile.

—Kay